DOXIL doses up to 90 mg must be diluted in 250 mL of 5% Dextrose Injection, USP prior to administration. Doses exceeding 90 mg should be diluted in 500 mL of 5% Dextrose Injection, USP …

Dec 5, 2025 · The recommended dose of DOXIL liposomal infusion is 30 mg/m 2 intravenously over 60 minutes on day 4 of each 21-day cycle for eight cycles or until disease progression or unacceptable …

Doxil package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

An ANDA must identify a listed drug on which it seeks to rely and, with limited exceptions, an ANDA must have the same active ingredient, strength, dosage form, route of administration, conditions of …

May 31, 2022 · The active ingredient in DOXIL liposomal infusion is doxorubicin hydrochloride, an anthracycline topoisomerase inhibitor, that is encapsulated in STEALTH liposomes for intravenous use.

FDA label information about doxorubicin (liposomal) for health professionals: link to the FDA-approved drug label (s) on the DailyMed website.

Aug 31, 2023 · Inform patients that following DOXIL liposomal infusion administration, a reddish-orange color to the urine and other body fluids may be observed. This nontoxic reaction is due to the color of …

2 labeling results FDALabel, NCTR Drug Label Search Application

Detailed FDA approval information for DOXIL, including regulatory status, product details, and official drug labeling information.

Get all the details for National Drug Code (NDC) 0338-0063 in one place. This page breaks down everything you need to know about the NDC, including proprietary name, active and inactive …